5Peppa-Patrikiou M,Dracopoulou M,Dacou-Voutetakis C,et al.Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus:relation to urinary albumin,blood pressure,and other factors[J].Metabolism,1998,47(11):1408-1412.
6Navarro-González JF,Mora-Fernández C.The role of inflammatory cytokines in diabetic nephropathy[J].J Am Soc Nephrol,2008,19(3):433-442.
7Okada T,Matsumoto H,Nakao T,et al.Effect of dietary protein restriction and influence of proteinuria on progression of type 2 diabetic renal failure[J].Nippon Jinzo Gakkai Shi,2000,42(5):365-373.
8Manchanda SC.Treatment of stable angina with low dose diltiazemin combination with the metabolic agent trimetazidine.Int J Cardiol,2003,88:83-89.
9Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxi-dation to glucose oxidation by inhibiting mitochondrial long-chain3-ketoacyl coenzyme a thiolase.Circ Res,2000,86(5):580-588.
2Zhang H,Long M,Wu Z,et al.Sodium tanshinoneⅡA silate as an add-on therapy in patients with unstable angina pectoris[J].J Thorac Dis,2014,6(12):1 794.
3Ishikawa T,Hatakeyama K,Imamura T,et al.Increased adrenomedullin immunoreactivity and m RNA expression in coronary plaques obtained from patients with unstable angina[J].Heart,2005,90(10):1 206.
